Maternal Serum Vascular Endothelial Growth Factor in Patients with Preeclampsia

Abstract

The aim of this study was to estimate maternal serum vascular endothelial growth factor levels in patients with preeclampsia compared to normotensive pregnant women. The study was carried out at the Department of Obstetric and Gynecology in Ain Shams University, we recruited 150 pregnant women after 28 weeks of gestation and they were classified into 3 groups: • Group 1: 50 women diagnosed with mild preeclampsia from 28 weeks of gestation till term. • Group 2: 50 women diagnosed with severe preeclampsia from 28 weeks of gestation till term. • Group 3: 50 normal pregnant women serving as controls. The inclusion criteria for this study were Primigravida, of gestational age between 28 weeks till term, singleton, viable pregnancy, with no medical or obstetric complications of pregnancy, no medications received during pregnancy except tonics and vitamins.